Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Report ID | 13528 |
Drug Identification Number | 02443449 |
Brand name | MYLAN-NAPROXEN/ESOMEPRAZOLE MR |
Common or Proper name | NAPROXEN/ESOMEPRAZOLE MR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE NAPROXEN |
Strength(s) | 20MG 500MG |
Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60BT |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-05-15 |
Actual start date | |
Estimated end date | 2019-05-22 |
Actual end date | 2019-05-22 |
Shortage status | Resolved |
Updated date | 2019-05-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v65 | 2019-04-03 | English | Compare |
v64 | 2019-03-08 | French | Compare |
v63 | 2019-03-08 | English | Compare |
v62 | 2019-03-05 | French | Compare |
v61 | 2019-03-05 | English | Compare |
v60 | 2019-02-21 | French | Compare |
v59 | 2019-02-21 | English | Compare |
v58 | 2019-01-18 | French | Compare |
v57 | 2019-01-18 | English | Compare |
v56 | 2019-01-08 | French | Compare |
v55 | 2019-01-08 | English | Compare |
v54 | 2018-12-06 | English | Compare |
v53 | 2018-12-05 | French | Compare |
v52 | 2018-12-05 | English | Compare |
v51 | 2018-11-30 | French | Compare |
v50 | 2018-11-30 | English | Compare |
v49 | 2018-11-20 | French | Compare |
v48 | 2018-11-20 | English | Compare |
v47 | 2018-10-16 | French | Compare |
v46 | 2018-10-16 | English | Compare |